Canopy Growth (CGC) Receivables - Net (2017 - 2025)
Canopy Growth's (CGC) quarterly Receivables - Net came in at $20.8 million in Q4 2025, down 40.77% year-on-year from $35.1 million in Q4 2024, and up 6.56% quarter-over-quarter from $19.5 million in Q3 2025.
Canopy Growth (CGC) Receivables - Net (2017 - 2025) Analysis & Trends
Canopy Growth has disclosed Receivables - Net across 9 years of filings, most recently posting $20.8 million for Q4 2025.
- Receivables - Net for Q4 2025 came in at $20.8 million, down 40.77% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.8 million (down 40.77% YoY), and the FY2025 annual result was $33.1 million, down 13.94% from the prior year.
- Receivables - Net came in at $20.8 million for Q4 2025 at Canopy Growth, up from $19.5 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $95.6 million in Q2 2023 to a low of $19.5 million in Q3 2025.
- The 5-year median for Receivables - Net is $39.6 million (2023), against an average of $49.1 million.
- Across the five-year window, Receivables - Net surged 133.99% in 2021 and sank 61.1% in 2024, its largest moves.
- Canopy Growth's Receivables - Net stood at $65.5 million in 2021, then declined by 8.11% to $60.2 million in 2022, then slumped by 37.8% to $37.4 million in 2023, then decreased by 6.18% to $35.1 million in 2024, then plunged by 40.77% to $20.8 million in 2025.
- The last three Receivables - Net figures came in at $20.8 million (Q4 2025), $19.5 million (Q3 2025), and $36.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.80 Mn |
| Dec 31, 2025 | 20.80 Mn |
| Sep 30, 2025 | 19.52 Mn |
| Sep 30, 2025 | 19.52 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Jun 30, 2025 | 36.11 Mn |
| Mar 31, 2025 | 33.11 Mn |
| Mar 31, 2025 | 33.11 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Dec 31, 2024 | 35.12 Mn |
| Sep 30, 2024 | 30.69 Mn |
| Sep 30, 2024 | 30.69 Mn |
| Jun 30, 2024 | 37.21 Mn |
| Jun 30, 2024 | 37.21 Mn |
| Mar 31, 2024 | 38.48 Mn |
| Mar 31, 2024 | 38.48 Mn |
| Dec 31, 2023 | 37.43 Mn |
| Dec 31, 2023 | 37.43 Mn |
| Sep 30, 2023 | 40.68 Mn |
| Sep 30, 2023 | 40.68 Mn |